Highlights from the 2016 HIV diagnostics conference: The new landscape of HIV testing in laboratories, public health programs and clinical practice

Wesolowski, Laura G.; Parker, Monica M.; Delaney, Kevin P.; Owen, S. Michele

doi:10.1016/j.jcv.2017.01.009

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

Highlights from the 2016 HIV diagnostics conference: The new landscape of HIV testing in laboratories, public health programs and clinical practice

6 2017
By Wesolowski, Laura G. ; Parker, Monica M. ; Delaney, Kevin P. ; ...
http://dx.doi.org/10.1016/j.jcv.2017.01.009
Source: J Clin Virol. 91:63-68

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

J Clin Virol
Personal Author:

Wesolowski, Laura G. ; Parker, Monica M. ; Delaney, Kevin P. ; Owen, S. Michele

Wesolowski, Laura G. ; Parker, Monica M. ; Delaney, Kevin P. ; Owen, S. Michele Less -
Description:

The 2016 HIV Diagnostics Conference, held in Atlanta, Georgia, was attended by public health officials, laboratorians, HIV testing program managers, surveillance coordinators and industry representatives. The conference addressed test performance data, the implementation of new testing algorithms, quality assurance, and the application of new tests in a variety of settings. With regard to the recommended Centers for Disease Control and Prevention/Association of Public Health Laboratories HIV laboratory testing algorithm, the conference featured performance data, implementation challenges such as a lack of test options for the second and third steps, as well as data needs for new tests that may be used as part of the algorithm. There are delays when nucleic acid testing is needed with the algorithm. Novel tests such as point of care nucleic acid tests are needed on the U.S. market to readily identify acute infection. Multiplex tests are being developed which allow for the simultaneous detection of multiple pathogens. CDC staff highlighted new guidance for testing in non-clinical settings. Innovative approaches to linking testing and care in some settings have led to identification of early infections, improved receipt of test results and expedited initiation of therapy. Work continues to optimize testing so that infections are accurately identified as early as possible and time to treatment is minimized to improve health outcomes and prevent transmission.
Subjects:

[+]

AIDS Serodiagnosis Algorithms Centers For Disease Control And Prevention, U.S. Congresses As Topic Data Accuracy Health Plan Implementation HIV-1 HIV-2 HIV Infections Humans Mass Screening Molecular Diagnostic Techniques Nucleic Acid Amplification Techniques Public Health RNA, Viral United States
Keywords:

[+]

Algorithm Conference Diagnostics HIV Testing
Source:

J Clin Virol. 91:63-68
Pubmed ID:

28209395
Pubmed Central ID:

PMC5440191
Document Type:

Journal Article
Funding:

CC999999/Intramural CDC HHSUnited States/
Volume:

91
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha256:32d0080a6632f3555bdad9e016597a68028d24e782922fff13d490c54f771d17
Download URL:

https://stacks.cdc.gov/view/cdc/45863/cdc_45863_DS1.pdf
File Type:

[PDF-72.74 KB]

nihms852207.nxml

xml